The expansive Swedish Gothenburg-based pharmaceutical company ABIGO Medical AB is benefiting from the debate concerning bacteria. In order to meet demand, SEK 10 million is being invested in the second half of 2012.
Business is good for the Gothenburg-based family-owned pharmaceutical company, ABIGO Medical AB. The company's Askersund factory is Sweden's only factory which produces advanced wound-healing products. The factory, which was opened in 2008 by Minister of Health and Social Affairs Göran Hägglund, is already in need of expansion. During the current half-year, the company is investing SEK 10 million in new machinery and an extension to the premises. The factory is currently working two shifts. ABIGO Medical AB is a complete company with its own research and development, production and marketing. As the company is wholly owned by brothers Jan and Leif Smith, there is not considered to be any need for widespread publicity, and a long-term approach can be adopted to developing and growing the company. The ability to treat wounds and fungal infections effectively without using antibiotics is an important aspect of the work relating to resistance development. ABIGO's unique patented Swedish wound-healing products represent an important contribution to this problem and are currently in use in 65 countries. A launch is currently under way in the USA. The products are based on the results of two senior Swedish professors and constitute an area within which ABIGO is continuing to research. The aim is to become a leading international company within the field and the company is already well on the way to achieving this aim. The unique products are effective, well-documented, have no known side-effects and no negative environmental impact. The company's research is cutting edge internationally and will result in new launches in the coming years.